Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
Terminated · Phase 2 · NCT05785715
Conditions: Ulcerative Colitis
At a glance
- Research payments reported, 2025
- $530,447
- U.S. investigators named
- 15
- Sites paid
- 11
- Planned or actual enrollment
- 81
About the trial
- Sponsor
- AbbVie
- Tested
- NX-13 250mg (drug), NX-13 750mg (drug), NX-13 Placebo (drug)
- Dates
- Started 2023-04-24; completion 2025-05-30
- Results posted
- Yes
Phase 2 induction study with a long-term extension (LTE) period in participants with moderate to severe ulcerative colitis (UC).
From ClinicalTrials.gov, last updated 2026-06-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $530,447 in research payments for this study in 2025 (73 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Blair T. Lacy, M.D. OB-GYN (Obstetrics & Gynecology) · Birmingham, AL
- Keila Hoover, M.D. Family Medicine · Miami, FL
- Udayakumar Navaneethan, MD Gastroenterology · Saint Petersburg, FL
- Alan M. Weintraub, MD Gastroenterology · Tampa, FL
- Daniel S. Mishkin, M.D. Gastroenterology · Weymouth, MA
- Ronald Fogel, MD Gastroenterology · Chesterfield, MI
- Partha S. Nandi, MD Gastroenterology · Troy, MI
- Parakkal Deepak, MD Gastroenterology · Saint Louis, MO
- Blair S. Lewis, M.D. Gastroenterology · New York, NY
- David S. Stokesberry, M.D. Gastroenterology · Oklahoma City, OK
- Elise R. Wiesner, MD Internal Medicine · Norman, OK
- Timothy E. Ritter, M.D. Gastroenterology · Southlake, TX
- Harry E. Sarles, M.D. Gastroenterology · Rockwall, TX
- Moustafa A. Youssef, M.D. Gastroenterology · Mansfield, TX
- Poonam Beniwal-patel, M.D. Gastroenterology · Milwaukee, WI
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Gcp Clinical Research LLC $265,794
- Miami Clinical Research LLP $83,386
- Washington University $68,446
- Texas Digestive Disease Consultants PLLC $28,468
- Orlando Health, FL $20,795
- Miami Clinical Research Lllp $17,687
- The Medical College of Wisconsin Inc $15,377
- Clinical Research Institute of Michigan LLC $14,748
- Gi Reviewers LLC $11,250
- Digestive Disease Specialists Inc $2,998
- Central Sooner Research $1,498
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.